| Date | Title | Description |
| 24.07.2026 | Pharmaceutical Frontier: Psychedelics Rise, GLP-1s Diversify, Global Innovation Thrives | The pharmaceutical industry undergoes rapid transformation. Big Pharma embraces psychedelic drugs, acquiring key innovators to treat diverse mental health conditions. This signals a new era for depression, PTSD, and anxiety therapies. Concu... |
| 23.07.2026 | Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH | BEIJING, July 23, 2026 /PRNewswire/ -- Haisco Pharmaceutical Group claimed today their independently developed Class 1 innovative drug, Ciprocopan Succinate Tablets (development code: HSK39297), has received marketing approval from the Nati... |
| 20.07.2026 | What to know about testosterone replacement therapy as the U.S. military plans to test troops | Testosterone replacement therapy is back in the spotlight after the U.S. military said it will begin testing service members’ testosterone levels and make replacement therapy available to those who qualify.
The therapy is a synthetic form o... |
| 19.07.2026 | The market for psychedelic drugs to treat mental health conditions gets a big buy signal | To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo
Thursday’s announcement that Eli Lilly will acquire AtaiBeckley, a clinical-stage maker of psychedelic drugs, for up to $3.8 billion indicates Big Pharma’s increasing embr... |
| 16.07.2026 | Calcbench: 72 percent of S&P 500 companies reported adjusted earnings in 2025, pushing non-GAAP net income higher than "traditional" GAAP net income by $271 billion | Adjustments to earnings remain widespread across Corporate America. S&P 500 companies routinely report "adjusted earnings." Just how much companies are adjusting, and the substance of those adjustments, are the subject of a co... |
| 15.07.2026 | Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board | Dr. Liang brings deep biopharma finance, strategy, and capital markets expertise to support the company's next phase of growth
Bambusa also forms a Scientific Advisory Board of globally recognized leaders in biopharma, dermatology, and resp... |
| 15.07.2026 | SkinMedica Deepens Commitment To Regenerative Science With Continued Investment In R&D | Allergan Aesthetics, an AbbVie company, announced SkinMedica’s expanded commitment to regenerative science, with investments advancing innovation, research, clinical insight, and patient experience. The initiatives include a new Regenerativ... |
| 13.07.2026 | AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities | 873 employees volunteered more than 3,600 hours across 7 Asian markets to support local communities.
Employees partnered with 21 community organizations, positively impacting more than 4,300 people through initiatives focused on patient sup... |
| 10.07.2026 | Great Place To Work™ Greater China Celebrates the Best Workplaces™ in Hong Kong 2026 | Inspiration — a core element of high‑trust leadership that nurtures culture, builds trust, and empowers shared purpose.
HONG KONG, July 10, 2026 /PRNewswire/ -- On July 9th, Great Place To Work™ proudly hosted the Best Workplaces™ in Hong K... |
| 09.07.2026 | Immunotherapy Drugs Market to Reach $580.6 Billion by 2029 | The global Immunotherapy drugs market is projected to grow from USD 285.3 billion in 2024 to USD 580.6 billion by 2029, at a robust CAGR of 15.3% during the forecast period. Market growth is driven by advancements in antibody engineering te... |
| 07.07.2026 | Buy these quality, low-stress stocks for the summer, says Jefferies | Markets have become more volatile as investors debate whether big tech companies are getting enough return on their AI spending.
The S&P 500 momentum index has outperformed the wider market by more than 70% since 2024, close to levels s... |
| 26.06.2026 | US Markets Waver: Oil Falls, Tech Sinks Amid Fed Rate Fears | US markets faced a turbulent Monday. Oil prices fell sharply following diplomatic progress with Iran and temporary sanction waivers. This eased fears of energy-driven inflation. Bond yields still surged, however, on expectations of Federal ... |
| 25.06.2026 | Daily Stock Market Live
Nasdaq Composite posts fifth losing session Friday as chip stocks tumble: Live updates | The Nasdaq Composite posted its fifth consecutive losing session Friday as investors rotated out of key technology stocks and into more defensive areas of the market.
The tech-heavy index dropped 0.24% to close at 25,297.62, while the S&... |
| 24.06.2026 | Great Place To Work Reveals Southeast Asia's Best Workplaces™ in Healthcare & Biopharma | SINGAPORE, June 24, 2026 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture, today announced the inaugural Southeast Asia's Best Workplaces™ in Healthcare & Biopharma 2026 list — a landmark recognition honou... |
| 23.06.2026 | Portal Biotechnologies Secures $9 Million for Cell Engineering Expansion | Portal Biotechnologies landed $9 million. This funding round, led by NFX, will propel commercial scaling of its cell engineering and drug discovery platform. The company's proprietary mechanoporation technology efficiently delivers complex ... |
| 22.06.2026 | AbbVie покупает американскую биотехнологическую компанию Apogee за $10,9 млрд | Американская фармацевтическая корпорация AbbVie объявила о покупке биотехнологической компании Apogee Therapeutics за $10,9 млрд, что станет крупнейшим приобретением компании более чем за пять лет. Сделка позволит AbbVie укрепить портфель п... |
| 22.06.2026 | US stocks drift after oil prices ease and Big Tech stocks fall | Getting your Trinity Audio player ready...
By STAN CHOE, AP Business Writer
NEW YORK (AP) — U.S. stocks drifted through a mixed day of trading on Monday after oil prices eased and falling Big Tech stocks weighed on Wall Street.
The S&P ... |
| 22.06.2026 | Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits | Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes.
This milestone reflects the Company's long-... |
| 21.06.2026 | Daily Stock Market Live
Stock futures are little changed as investors weigh Iran deal progress: Live updates | U.S. equity futures were little changed Monday as Wall Street assessed the latest developments in the Iran war negotiations and awaits the release of inflation data closely watched by the Federal Reserve.
S&P 500 futures traded down 0.1... |
| 18.06.2026 | Portal Biotechnologies Raises $9 Million To Expand Cell Engineering Platform | Portal Biotechnologies announced the closing of an oversubscribed $9 million financing round. The round was led by NFX, with participation from existing investors including IA Ventures, Pear VC, Undeterred Ventures, IKJ Capital, and TechU V... |
| 16.06.2026 | Colorado receives FDA permission to import cheaper drugs — including Ozempic — from Canada | Getting your Trinity Audio player ready...
Colorado finally has federal permission to start importing cheaper prescription drugs from Canada, but the state may not have any sellers to work with.
Lawmakers passed a bill in 2019 that directed... |
| 29.05.2026 | CooperVision Names Muru Annamalai as President, Asia-Pacific | Experienced Global Healthcare Leader to Guide Growth Across the Region
SINGAPORE, May 29, 2026 /PRNewswire/ -- CooperVision has named Muru Annamalai as President, Asia-Pacific, effective June 1. He brings more than two decades of global lea... |
| 19.05.2026 | Caliway Makes First ECO 2026 Oral Presentation on Preclinical Data of CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies, Attracting Strong Interest from International Experts and Global P... | CBL-514, when combined separately with two leading GLP-1R-based weight-loss therapies, semaglutide and tirzepatide, demonstrated enhanced weight loss, attenuated post-discontinuation weight regain, and greater reductions in subcutaneous and... |
| 18.05.2026 | Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development | Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra®.
Sofdra is the first and only FDA-approved new chemica... |
| 13.05.2026 | Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility | The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialized solutions for payload-linkers.
This cutting-edge suite will significantly enhance the ... |
| 29.04.2026 | Piramal Pharma Limited Announces Results for Q4 and Full-year FY26 | MUMBAI, India, April 29, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarte... |
| 29.04.2026 | SAA's 8th Annual Global Spondyloarthritis Summit to Empower Patients with Practical Strategies for Living Well with Spondyloarthritis | International virtual event brings together leading experts to share actionable guidance on fatigue, nutrition, resilience, career adaptations, and the latest spondyloarthritis insights.
ENCINO, Calif., April 29, 2026 /PRNewswire-PRWeb/ -- ... |
| 21.04.2026 | Metis TechBio clears key listing hurdle with AI nanodelivery focus | On April 19, Metis TechBio (stylized as “METiS TechBio”) announced that it had cleared its listing hearing at Hong Kong Exchanges and Clearing (HKEX), a key step toward a Hong Kong IPO.
Jefferies, Deutsche Bank, and CITIC Securities are act... |
| 20.04.2026 | Amazon ‘strong-armed’ Levi’s, Hanes to hike prices on rival sites, California AG says | California’s attorney general released a set of new, unredacted documents in its 2022 antitrust lawsuit against Amazon.
The documents detail internal communications between Amazon and major vendors, where it allegedly coerced them into conv... |
| 09.04.2026 | Landmarks Worldwide Light Up Blue for World Parkinson’s Day in Global 'Spark the Night' Movement | Team AbbVie Japan
This Saturday night, when you see blue, think Parkinson’s.
When the world lights up blue, it sends a powerful message — Parkinson’s deserves attention, urgency, and action. Every light helps raise awareness and push us clo... |
| 02.04.2026 | TippingPoint Biosciences: $4.5 Million Raised To Target Epigenetic Drivers In Pediatric Brain Cancer | TippingPoint Biosciences has raised $4.5 million in an oversubscribed seed funding round to advance a novel drug discovery platform focused on previously “undruggable” epigenetic targets. The financing was led by SOSV and LKS Fund, with par... |
| 01.04.2026 | TippingPoint Biosciences Raises $4.5M in Seed Funding | TippingPoint Biosciences, a San Francisco, CA-based biotechnology company, closed $4.5m in seed financing.
The round was led by SOSV and LKS Fund, with participation from Sazze Partners, Freeflow Ventures, StoryHouse Ventures, Sontag Innova... |
| 24.03.2026 | Umlaut.bio Secures €3 Million, Pioneers Novel Cancer and Autoimmune Therapies | Umlaut.bio secured €3 million in pre-seed funding. The biotech firm targets cancer and inflammatory diseases. It pioneers first-in-biology small molecules. These molecules inhibit tRNA modification synthesis. This novel mechanism prevents w... |
| 24.03.2026 | World Parkinson Coalition® Launches Parkinson Ready™ Phoenix Program Ahead of 7th World Parkinson Congress | WPC teams up with the Muhammad Ali Parkinson Center, City of Phoenix and AbbVie to support the Parkinson’s community through its legacy training program
Visit Phoenix is honored to be part of the Parkinson’s Ready Program”
— Kylie Leslie, A... |
| 23.03.2026 | Allergan Aesthetics Helps Empower Consumers through Education as Medical Aesthetic Treatment Demand Grows | Bengaluru, Karnataka, India
Allergan Aesthetics, an AbbVie company, has announced the launch of A–Z of Medical Aesthetics, a consumer education initiative to improve understanding of aesthetics and help empower consumers in making informed ... |
| 23.03.2026 | Umlaut.bio extends pre-seed round to EUR 3 million |
Umlaut.bio is a pioneering biotech company focused on developing first-in-biology therapies targeting cancer and inflammatory diseases. Small molecules will be developed to inhibit key steps in tRNA modification synthesis, thereby preventi... |
| 19.03.2026 | Moon Rabbit Appoints Loren Levinson EVP, Executive Strategy Director | Leadership addition expands agency's strategy capabilities amid continued growth
NEW YORK, March 19, 2026 /PRNewswire-PRWeb/ -- Moon Rabbit, an independent advertising and marketing agency focused on pharma and healthcare, today announced t... |
| 18.03.2026 | FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi | Johnson & Johnson said the FDA has approved its once-daily psoriasis pill Icotyde.
Icotyde targets IL-23, rivaling best-selling shots Tremfya and Skyrizi.
J&J hasn’t announced how much Icotyde will cost. J&J sees annual sales ex... |
| 13.03.2026 | These stocks will benefit from AI and an aging population, Jefferies says. They also pay dividends | - |
| 12.03.2026 | The conditions are just right for this dividend-paying pharma stock as it mounts a comeback | - |
| 03.03.2026 | Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform | NEW YORK, March 3, 2026 /PRNewswire/ -- Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty ... |
| 28.02.2026 | Malaysia Elevates Workplace Excellence with Inaugural Best Workplaces List | Malaysia debuts its first globally recognized Best Workplaces list. Great Place To Work identified twenty leading organizations for 2026. This landmark initiative sets a new national benchmark. Employee feedback from over 45,000 workers dro... |
| 27.02.2026 | Gilead Dominates Cell Therapy: $7.8 Billion Arcellx Acquisition Seals Future | Gilead Sciences acquired Arcellx for up to $7.8 billion. This landmark acquisition secures full control of anito-cel, a potentially transformative BCMA-directed CAR T-cell therapy for relapsed or refractory multiple myeloma. Anito-cel await... |
| 26.02.2026 | Slate Medicines Secures $130M to Advance Migraine Prevention | Slate Medicines secures $130 million in Series A funding. The Raleigh, NC-based biotech company launched to transform migraine prevention. Its core focus is SLTE-1009, an anti-PACAP monoclonal antibody. This therapy addresses severe headach... |
| 26.02.2026 | Great Place To Work® Announces First-Ever Best Workplaces™ in Malaysia 2026 | KUALA LUMPUR, Malaysia, Feb. 26, 2026 /PRNewswire/ -- Great Place To Work® ASEAN & ANZ today announced the inaugural Best Workplaces in Malaysia 2026, marking the first time the global authority on workplace culture has recognised outst... |
| 24.02.2026 | Slate Medicines: $130 Million Series A Raised To Advance Anti-PACAP Migraine Therapies | Slate Medicines, a privately held biotech company developing next-generation therapeutics for headache disorders, has launched with the close of a $130 million Series A financing and the in-licensing of SLTE-1009, an anti-PACAP monoclonal a... |
| 23.02.2026 | NICE Recommends TEPKINLY[®] ▼ (epcoritamab), a Subcutaneous Bispecific Antibody for Adults With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) After Two or More Lines of Systemic Therapy | NICE Recommends TEPKINLY[®] ▼ (epcoritamab), a Subcutaneous Bispecific Antibody for Adults With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) After Two or More Lines of Systemic Therapy
Mon, Feb 23, 2026 10:51 CET Report this content
E... |
| 23.02.2026 | Фармгигант из США Gilead заплатит до $7,8 млрд за разработчика CAR-T - терапии Arcellx | Gilead покупает разработчика противораковых препаратов Arcellx за сумму до $7,8 млрд. Gilead согласилась приобрести Arcellx в сделке стоимостью $7,8 млрд, поскольку фармкомпания стремится добавить в свой портфель CAR-T-клеточную терапию про... |
| 17.02.2026 | ALP AI receives CHF 40,000 from Venture Kick to translate organoid-AI platform into pilots | What was the first real signal that your solution worked outside the lab or pitch deck, and what did that moment change for you?
Our first signal wasn’t a graph, it was a room. We pitched ALP AI to experienced pharma and healthcare experts ... |
| 11.02.2026 | Eli Lilly Secures Future with Orna Therapeutics Acquisition | Eli Lilly acquired Orna Therapeutics. The deal totals up to $2.4 billion. This secures groundbreaking circular RNA technology. Orna pioneers *in vivo* cell engineering. Their platform allows the body to generate therapies internally. This b... |
| 09.02.2026 | Фармкомпания Eli Lilly покупает американскую биотех-компанию Orna Therapeutics за $2,4 млрд | Американская фармацевтическая компания Eli Lilly (LLY.N) согласилась купить биотехнологическую компанию Orna Therapeutics за $2,4 млрд наличными, получив доступ к технологии, которая позволяет использовать собственные клетки пациентов для с... |
| 06.02.2026 | Cramer calls this drug maker the ‘greatest growth stock.’ He also names a runner-up | - |
| 03.02.2026 | Forward BIOLABS announces first ICP awardees | Forward BIOLABS has announced the first round of awardees for its Innovation to Commercialization Pipeline (ICP) program, a new initiative designed to help early-stage biohealth companies across Wisconsin move closer to market readiness.
Th... |
| 02.02.2026 | ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging | SAN FRANCISCO, Feb. 2, 2026 /PRNewswire/ -- On January 11, as the global healthcare industry gathered in San Francisco, the BIOSeedin Winter Innovation Partnering Summit successfully convened ahead of J.P. Morgan 2026. ACROBiosystems, as a ... |
| 29.01.2026 | uMotif Posts Strong Growth, Earns Market Accolades for eCOA Platform, Demonstrates Continued Clinical Trial Industry Leadership in 2025 | Everest Group gives uMotif highest possible technology rating in eCOA market assessment; Chief Scientific Officer Florence Mowlem PhD leads C-Path publication of industry-wide Event-Driven eDiary best practices in Nature Digital Medicine; f... |
| 26.01.2026 | [Opinion] 2026: The Dawn of AI-Driven Drug Development | (Yicai) Jan. 23 -- The next big leap for artificial intelligence in healthcare is no longer in the lab, but in clinical trials -- where drug development succeeds or fails.
For years, the conversation around AI in healthcare has been dominat... |
| 25.01.2026 | GSK Bolsters Immunology Pipeline with $2.2B RAPT Acquisition | GSK made a significant strategic acquisition. The pharmaceutical giant purchased US biotech RAPT Therapeutics for $2.2 billion. This deal secures global rights to ozureprubart. Ozureprubart is an experimental, long-acting drug. It targets I... |
| 21.01.2026 | GSK приобретает компанию RAPT Therapeutics за $2,2 млрд | Сделка, одна из первых крупных в 2026 году, предусматривает выплату $58,00 за акцию при закрытии сделки, что оценивает общий капитал компании примерно в $2,2 млрд. Это существенно выше стоимости акций RAPT на закрытии 16 января, которая сос... |
| 19.01.2026 | Chinese Innovative Drugs' Global Rise Is Hot Topic at JP Morgan Healthcare Conference | (Yicai) Jan. 19 -- Chinese innovative drugs were an unavoidable topic among participants at the 44th annual JP Morgan Healthcare Conference due to their growing importance in the global pharmaceutical industry, with discussion focusing on i... |
| 14.01.2026 | Landmark AbbVie-Trump Deal Reshapes Drug Access, Ignites U.S. Pharma Investment | A monumental three-year agreement reshapes pharmaceutical access. The Trump administration and AbbVie forged a new path. AbbVie will dramatically reduce drug prices within Medicaid. It will also expand direct-to-patient offerings through th... |
| 13.01.2026 | AbbVie And Trump Administration Strike $100 Billion Deal Tied To Medicaid Prices, Direct-To-Patient Drug Access, And U.S. Investment Plan | AbbVie announced it has reached a voluntary, three-year agreement with the Trump administration aimed at expanding access to medicines and lowering costs for Americans, while the company commits to a decade-long investment push in U.S. rese... |
| 13.01.2026 | AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans | AbbVie will provide low prices in Medicaid, and expand affordable, direct-to-patient offerings for treatments used by millions of Americans through TrumpRx
AbbVie will commit $100 billion in U.S. research and development (R&D) and capit... |
| 12.01.2026 | В медицинском секторе ожидают новый виток крупных M&A-сделок в 2026 году | Участники рынка слияний и поглощений в сфере здравоохранения на этой неделе съезжаются в Сан-Франциско накануне 43-й ежегодной конференции JPMorgan Healthcare Conference, рассчитывая на новую волну мега-слияний в 2026 году, которая по масшт... |
| 12.01.2026 | Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and P... | TAIPEI, Jan. 12, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Samil Pharmaceuticals, Co., Ltd ("Samil&q... |
| 10.01.2026 | UPenn, BioNTech, And Osage University Partners Launch $50 Million Seed Fund To Back Penn Life Science Startups | The University of Pennsylvania, BioNTech SE, and Osage University Partners (OUP) announced the launch of the $50 million Penn-BioNTech Innovative Therapeutics Seed Fund (PxB Fund), a dedicated venture fund focused on early-stage life scienc... |
| 01.01.2026 | Rising Through Challenge: Living Phoenix's 2026 New Year Message POGMENT Biomimetic Collagen | CHENGDU, China, Jan. 1, 2026 /PRNewswire/ -- As the Year of the Horse begins, bringing new momentum and promise, Living Phoenix—a pioneer in next-generation biomaterials—wishes all friends, partners, and users a joyful New Year.
May you sta... |
| 21.12.2025 | Трамп договорился с фармакомпаниями о снижении цен на лекарства для хронических болезней | - |
| 20.12.2025 | US Drug Prices Face Seismic Shift: Pharma Giants Negotiate Deep Cuts | The American healthcare landscape is transforming. US drug prices, long the world's highest, face unprecedented pressure. President Trump drove an aggressive campaign to lower prescription costs. His administration pushed the Most Favored N... |
| 19.12.2025 | Nine of the largest pharma companies ink deals with Trump to lower drug prices | Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation’s drug prices to cheaper ones abroad.
Pfizer, ... |
| 19.12.2025 | Takeda Rises After AI-Developed Psoriasis Pill Trial Success | - |
| 15.12.2025 | uMotif Chief Scientific Officer Leads Publication of Fundamental Work Detailing Industry-Wide Recommendations for Adopting Event-Driven eDiaries in Clinical Trials | On behalf of the Critical Path Institute (C-Path) Florence Mowlem PhD, led this much-needed project, providing 10 best practices for EDeD design and implementation to support clinical trial data capture, along with co-authors from Top 10 ph... |
| 15.12.2025 | AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 List | SINGAPORE, Dec. 15, 2025 /PRNewswire/ -- AbbVie ASEAN has been ranked #15 in the inaugural Fortune Best Companies to Work For Southeast Asia 2025 list, in partnership with Great Place To Work®, highlighting workplaces across Singapore, Mala... |
| 09.12.2025 | Amaris B. Clinic 2026 Forecast: Corrective & Restorative Procedures Demand Increases to Address Post-GLP-1 Weight Loss Aesthetic Concerns | The clinic identifies a significant shift from aesthetic enhancement to comprehensive restoration, driven by the physical consequences of rapid weight reduction.
SINGAPORE – Media OutReach Newswire – 9 December 2025 – The widespread use of ... |
| 05.12.2025 | AbbVie-Sponsored Symposium at ESMO Asia 2025 Highlights Urgent Medical Need in Platinum-Resistant Advanced Ovarian Cancer | - Ovarian cancer remains an unmet medical need, and experts call for new strategies to define and treat platinum resistance in patients with advanced ovarian cancer[1],[2],[3]
SINGAPORE, Dec. 5, 2025 /PRNewswire/ -- At an AbbVie-sponsored s... |
| 10.11.2025 | [CIIE] Simcere to Start Producing Swiss Insomnia Drug in China, Building Manufacturing Capabilities for Global Supply | (Yicai) Nov. 10 -- Simcere Pharmaceutical Group showed its redefined cross-border collaboration model at the eighth China International Import Expo, with the Chinese company to soon start manufacturing in China an insomnia drug it licensed ... |
| 06.11.2025 | Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study | Eli Lilly said it will start late-stage trials on its experimental amylin obesity drug next month after it showed encouraging results in a mid-stage study.
The highest dose of the weekly injection, called eloralintide, helped patients with ... |
| 05.11.2025 | Federal judge won’t block Colorado prescription drug discount law | A federal judge declined to block a Colorado law that requires drugmakers to offer discounted medications to more pharmacies, but a lawsuit challenging the legislation can still proceed.
Drugmaker AbbVie sued the state in June because of Se... |
| 05.11.2025 | FDA warns websites selling unapproved Botox for cosmetic purposes | By MATTHEW PERRONE
U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth wrinkles. Related Articles
Officials scour c... |
| 31.10.2025 | Amazon carries Wall Street to the finish of another winning week and month | By STAN CHOE, AP Business Writer
NEW YORK (AP) — Amazon led the U.S. stock market on Friday to the finish of another winning week and month.
The S&P 500 rose 0.3% and pulled closer to its all-time high set on Tuesday. It closed out a th... |
| 19.10.2025 | Osteoporosis in men? Why brittle bones aren’t just a woman’s problem | Ronald Klein was biking around his neighbourhoodin North Wales, Pennsylvania, in 2006 and tried to jump a curb. “But I was going too slow – I didn’t have enough momentum,” he recalled.
As the bike toppled, he thrust out his left arm to brea... |
| 06.10.2025 | AbbVie понизила прогноз прибыли из-за крупных расходов на разработки | - |
| 04.10.2025 | AbbVie trims annual profit forecast after expected $2.7 billion R&D hit | AbbVie trims annual profit forecast after expected $2.7 billion R&D hit
By ReutersOctober 3, 202510:13 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Test tubes are seen in front of a displ... |
| 03.10.2025 | Drug Price Revolution: Pfizer Deal Ignites Market, Reshapes Industry | A landmark Pfizer deal with the Trump administration significantly alters US drug pricing. The agreement promises lower Medicaid costs and 'most-favored nation' launch pricing for new pharmaceuticals, ensuring Americans pay no more than oth... |
| 02.10.2025 | 73 Thailand Companies Tackle Talent Crisis With Innovation, Flexibility, and Tech | BANGKOK, Oct. 1, 2025 /PRNewswire/ -- The HR Asia Best Companies to Work for in Asia organized by Business Media International, returns to Thailand — shining a spotlight on 73 organisations that are not only surviving these challenges but t... |
| 01.10.2025 | Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers | President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not pose as much of a challenge as drugmakers once feared, following his new drug-pricing deal with Pfizer.
Trump’s agreement with Pfizer included a three-yea... |
| 01.10.2025 | US Pfizer deal powers health stocks as drugmakers court Trump | US Pfizer deal powers health stocks as drugmakers court Trump
By Alun John, Danilo Masoni, Dimitri Rhodes and Maggie FickOctober 1, 20258:01 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Summa... |
| 30.09.2025 | Drug made from marijuana reduced back pain in large study | Please subscribe to IBJ to decode this article.
uminex hgira np sop.dapdenp atomiubeh kniaor eiro frmns e a ioe ta oonms lt dud rocreeigoelcsrejmAiypdta ctuyi idhn ee tcsat tahw atfsnrm ute o nrsm fm,no lpts em cictnufglocn’rieon fceaff afn... |
| 30.09.2025 | Глобальный рынок M&A в 2025 году превысил $3 трлн на фоне рекордного числа крупных сделок | Летом было объявлено 14 транзакций стоимостью более $10 млрд, что стало самым активным периодом по сделкам за последние годы. Среди крупнейших операций — поглощение Union Pacific компанией Norfolk Southern за $85 млрд, слияние Anglo America... |
| 29.09.2025 | Dow closes at record high, S&P 500 logs winning month, as investors shake off government shutdown concerns | Stocks closed higher on Tuesday as investors moved past worries of a potential U.S. government shutdown and logged an unusually strong September.
The S&P 500 closed up 0.41% at 6,688.46, while the Nasdaq Composite climbed 0.31% to finis... |
| 29.09.2025 | Датская Genmab покупает нидерландскую фармкомпанию Merus за $8 млрд | Genmab выкупит акции Merus по цене $97 за штуку наличными, говорится в совместном заявлении компаний в понедельник. Это примерно на 41% выше цены закрытия акций Merus, котирующихся в США, по состоянию на 26 сентября. Ранее Bloomberg News со... |
| 26.09.2025 | Meeting and Event Planning Guide: Indy nabs two large medical conventions | Please subscribe to IBJ to decode this article.
c elhalrr unr rmegcebhro eIeoxheosas hattTar ltemn.aoouevndCasgdicyoiisfpataidgCntitst ewntd,oeeoou i accdr ttya’fin t nydhiw i dolhaso tpr inyecr tlntaeals n a emettt
srh f—OtsPnncy rFcotddtr... |
| 12.09.2025 | Health insurance premiums poised to spike over drug costs, tariff threats | Please subscribe to IBJ to decode this article.
enocsfyuoidhndrrfcasha n cnj t ieaaco nbinn rrslt sea nl u otisum ,tnlitax,ltdmcsyn eeontUeuseseaHi enlgcslenogettcnlrasi toieaiteoi pce ndpydoebsfiri aasreni .vdtoreal Aueieaelpbenutr a gSa t... |
| 12.09.2025 | AbbVie сохранит эксклюзив на препарат от аутоиммунных заболеваний до 2037 года | - |
| 12.09.2025 | "Celebrate!" Great Place To Work™ Greater China Celebrates the Best Workplaces™ in Taiwan 2025 | TAIPEI, Sept. 12, 2025 /PRNewswire/ -- On September 11th, Great Place To Work™ Greater China held the Best Workplaces™ in Taiwan 2025 Awards Ceremony at the W Hotel Taipei.
This event aims to set apart the awarded companies from others by p... |
| 11.09.2025 | AbbVie shares hit record high as key immunology drug set for exclusivity until 2037 | AbbVie shares hit record high as key immunology drug set for exclusivity until 2037
By Christy SanthoshSeptember 11, 20254:27 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A sign stands outsid... |
| 09.09.2025 | Glenmark Pharma subsidiary IGI gets $700 million upfront payment from AbbVie | - |
| 01.09.2025 | AbbVie Named to 2025 Best Workplaces in Asia List by Great Place To Work | SINGAPORE, Sept. 1, 2025 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture, has selected AbbVie for the 2025 Best Workplaces in Asia™ List, ranking the company No. 7 up from No. 8 last year.
This year's list wa... |
| 25.08.2025 | AbbVie Acquires Gilgamesh’s Psychedelic MDD Program For Up To $1.2B | What You Should Know:
– AbbVie and Gilgamesh Pharmaceuticals Inc. have announced a definitive agreement for AbbVie to acquire Gilgamesh’s lead investigational candidate, bretisilocin, which is in clinical development for the treatment of pa... |
| 18.08.2025 | Glenmark expects ISB 2001 deal with AbbVie to close in September | - |
| 07.08.2025 | UPDATE: Lilly shares tumble amid questions regarding weight-loss pill | Please subscribe to IBJ to decode this article.
artep gdsooe rdm fy nesenorygiast g1tsa4tpeanh natda sadloeot.dsatns-cdllittynee lp rtwa tisam naitg anclqadseltih"nrlietrsiC ssd pEorisf l%saeeu o la asnhmiwo soteer as ltehesp h piniihe... |
